That's the honest summary: the Knig et al
Update 29, 395433
Optimized Metabolic Function The MindBody GLP-1 system represents a significant advancement in enhancing your body's innate capabilities to effectively manage critical functions such as blood sugar regulation and appetite control
doi: 10.1152/physrev.00066.2017
SingleCare prescription card A free SingleCare prescription discount card can help you save hundreds of dollars on a months supply of GLP-1 pills and injections
STEP-1 Trial (Semaglutide 2.4 mg, N=1,961) The STEP-1 trial published in the New England Journal of Medicine reported that among participants receiving semaglutide 2.4 mg subcutaneously once weekly, nausea occurred in 44.2%, diarrhea in 29.7%, vomiting in 24.5%, and constipation in 24.1%, compared to 16.0%, 15.9%, 6.8%, and 11.1% with placebo, respectively [3]